A. Montanini

发表

Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.

P. Gobbi, A. Levis, T. Chisesi, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anthracyclines: a cornerstone in the management of non-Hodgkin's lymphoma

M. Federico, S. Luminari, A. Montanini, 2011, Hematology reports.

The length of treatment of aggressive non‐Hodgkin's lymphomas established according to the international prognostic index score: long‐term results of the GISL LA03 study

P. Gobbi, S. Sacchi, M. Federico, 2006, European journal of haematology.

Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)

M. Federico, G. Buda, C. Stelitano, 2010, Supportive Care in Cancer.

Prognostic tools in follicular lymphomas

M. Federico, S. Luminari, M. Cox, 2009, Expert review of hematology.

ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.

F. Angrilli, P. Mazza, P. Gobbi, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial.

J. Briones, M. Federico, M. Petrini, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone outside German Hodgkin Study Group: The Italian experience

P. Gobbi, E. Iannitto, M. Federico, 2009 .

Role of glutathione-s-transferase (gst) polymorphisms in patients with advanced hodgkin lymphoma: results from the hd2000 GISL trial

P. Gobbi, E. Iannitto, M. Federico, 2012, Leukemia & lymphoma.

Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study

E. Iannitto, R. Marasca, A. Piccin, 2011, British journal of haematology.

Incidence, clinical characteristics and survival of malignant lymphomas: a population‐based study from a cancer registry in northern Italy

M. Federico, I. Rashid, A. Maiorana, 2007, Hematological oncology.

Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi

M. Federico, A. Liberati, S. Luminari, 2006, Leukemia & lymphoma.